Find Drugs for Hepatology (Liver, Pancreatic, Gall Bladder) in Phase II Clinical Development in NETHERLANDS

Lead Product(s): Icosabutate

Therapeutic Area: Hepatology (Liver, Pancreatic, Gall Bladder)

Highest Development Status: Phase II Product Type: Small molecule

Partner/Sponsor/Collaborator: venBio Partners

Deal Size: $40.0 million Upfront Cash: Undisclosed

Deal Type: Series B Financing January 08, 2020

Details:

Proceeds will be used to progress the SEFA development pipeline: Completion of Ph 2b study of lead programme Icosabutate in (NASH) Initiation of clinical development of two new programmes for (PNALD)